Camptosar

In the US, Camptosar (irinotecan systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Colorectal Cancer.

US matches:

• Camptosar

Ingredient matches for Camptosar

Irinotecan

Irinotecan hydrochloride trihydrate (a derivative of Irinotecan) is reported as an ingredient of Camptosar in the following countries:

• Argentina


• Australia


• Belize


• Brazil


• Canada


• Chile


• Colombia


• Costa Rica


• El Salvador


• Guatemala


• Honduras


• Mexico


• New Zealand


• Nicaragua


• Panama


• Peru


• United States


• Venezuela

International Drug Name Search